| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.097 | 0.03 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |